睡眠时间和表型衰老加速的调解之间的剂量反应关系:一个横截面研究
1Ministry of Basic Education, Inner Mongolia Minzu Preschool Education College, Ordos, China.
Medicine
|October 7, 2025
概括
获得足够的睡眠对于健康的衰老至关重要. 这项研究发现,每天睡眠7-9小时可能会减缓生物衰老,关键值约为6.7小时,但吸烟和糖尿病等个人因素很重要.
科学领域:
- 老年学和睡眠科学研究
- 生物标志物研究 生物标志物研究
- 公共卫生 公共卫生
背景情况:
- 生物衰老受生活方式因素的影响,包括睡眠时间.
- 现型年龄加速 (PhenoAgeAccel) 是生物衰老的衡量标准.
- 了解睡眠和衰老之间的剂量反应关系对于健康指导至关重要.
研究的目的:
- 为了研究睡眠时间和PhenoAgeAccel之间的剂量反应关系.
- 探索不同的睡眠模式如何影响生物衰老.
- 确定改变睡眠与衰老关系的人口和健康因素.
主要方法:
- 使用国家健康和营养检查调查数据 (2001-2010) 对8992名成年人进行的横截面研究.
- 睡眠时间分类为每天<7,7-9小时和>9小时.
- 用9个生物标志物计算PhenoAgeAccel;用加权通用线性回归和不受限制的立方轴线进行分析.
主要成果:
- 观察到睡眠时间和PhenoAgeAccel之间的非线性剂量反应关系,转折点约为6.7小时.
- 适度睡眠 (7-9小时) 显示了衰老减缓的趋势,但在完全调整后,这并不显著.
- 吸烟和糖尿病状态显著改变了睡眠时间和PhenoAgeAccel之间的关系.
结论:
- 适度睡眠时间 (7-9小时) 与生物衰老的减缓有关,临界值约为6.7小时.
- 睡眠不足 (<7小时) 和睡眠过多 (>9小时) 都可能对衰老产生负面影响.
- 卫生干预措施应考虑个人的吸烟和糖尿病状况,以实现个性化的睡眠和衰老策略.
相关概念视频
Pharmacodynamics in Geriatric Patients: Effects of Age
187
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
187
Insufficient Sleep and Sleep Deprivation
833
Insufficient sleep refers to not getting the recommended amount of sleep for optimal functioning, even if it's just slightly less than needed. Sleep insufficiency may occur due to lifestyle choices, such as staying up late for social events or work, resulting in routinely getting less sleep than required. For example, consistently sleeping 6 hours when the body needs 7-9 hours can lead to cumulative effects on health and well-being.
Sleep deprivation is a more severe form of sleep loss...
Sleep deprivation is a more severe form of sleep loss...
833
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
350
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
350
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
227
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
227
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
634
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
634
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
196
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
196


